Shire News

01 Feb 2012
Total Voting Rights
01 Feb 2012
Shire and Sangamo Collaborate to Develop Therapeutics for the Treatment of Hemophilia and Other Monogenic Diseases
31 Jan 2012
Full Year 2011 results date notification – February 9, 2012
23 Jan 2012
Notification of major interests in shares (27KB PDF)
10 Jan 2012
Shire Acquires US Rights to Resolor® (prucalopride)
05 Jan 2012
Shire’s VENVANSE® (lisdexamfetamine dimesylate) Marketing Application accepted for review in Europe
03 Jan 2012
Total Voting Rights